Zymeworks M&A Monday, June 29, 2026 0.00 Neutral

Zymeworks to merge with Theravance Biopharma

Zymeworks Inc. has entered into an agreement and plan of merger with Theravance Biopharma Inc. The deal, effective upon closing, includes terms for the exchange of securities and treatment of equity awards.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day